Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Olema Pharmaceuticals, Inc.”

7 pharma patents match "Olema Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "Olema Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “Olema Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 12428379

    Acylsulfonamide KAT6A inhibitors

    Olema Pharmaceuticals, Inc. · Granted Sep 30, 2025 · Expires Sep 25, 2045

    granted

  2. US 12370181

    Regimens of estrogen receptor antagonists

    Olema Pharmaceuticals, Inc. · Granted Jul 29, 2025 · Expires Jul 24, 2045

    granted

  3. US 11672785

    Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

    Olema Pharmaceuticals, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted

  4. US 11229630

    Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

    Olema Pharmaceuticals, Inc. · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  5. US 10624878

    Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

    Olema Pharmaceuticals, Inc. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  6. US 10292971

    Tetrahydro-1H-pyrido[3,4-b]indole anti-estrogenic drugs

    Olema Pharmaceuticals, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted

  7. US 9018244

    Benzopyran compounds, compositions and uses thereof

    Olema Pharmaceuticals, Inc. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.